MPS Pharmaa Ltd

MPS Pharmaa Ltd

₹ 3.21 0.00%
26 Mar - close price
About

Established in 1997, Advik Laboratories is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The company deals in a wide range of pharmaceuticals formulations like Tablets, Capsules and Dry Syrups, etc.

Key Points

Product Portfolio:[1]
a) WHO - GMP Certified Generic Products:[2]
Antibacterial
Antiallergics
Antifungals
Analgesic
Antipyretic
Anti-inflammatory
Anthelminthic
Antihypertensive
Antimalarial
Antituberculotic
Corticosteroids
Erectile Dysfunction
Gastrointestinal agents
Sedatives

b) WHO - GMP Certified Ethical Products:[3]
Wibatol
Robial
Twosum
Majispa
Arfa Gel
Stibomin
Chewfe-C

  • Market Cap 6.13 Cr.
  • Current Price 3.21
  • High / Low 3.21 / 2.10
  • Stock P/E
  • Book Value 1.27
  • Dividend Yield 0.00 %
  • ROCE -11.3 %
  • ROE -31.8 %
  • Face Value 10.0

Pros

Cons

  • Stock is trading at 2.52 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding is low: 35.9%
  • Company has a low return on equity of -43.4% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
3.61 0.22 0.17 0.15 0.19 0.19 0.17 0.24 0.23 0.31 0.19 0.21 0.18
Operating Profit -3.61 -0.22 -0.17 -0.15 -0.16 -0.19 -0.17 -0.24 -0.23 -0.31 -0.19 -0.21 -0.18
OPM % -533.33%
0.00 0.18 0.00 0.25 0.00 0.00 0.00 0.00 0.00 0.02 0.03 0.06 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.14 0.13 0.13 0.13 0.13 0.13 0.04 0.04 0.04 0.04 0.04 0.04 0.04
Profit before tax -3.75 -0.17 -0.30 -0.03 -0.29 -0.32 -0.21 -0.28 -0.27 -0.33 -0.20 -0.19 -0.22
Tax % 0.53% 11.76% 6.67% 66.67% 6.90% 231.25% 0.00% 0.00% 0.00% 3.03% 5.00% 5.26% 4.55%
-3.73 -0.15 -0.28 -0.01 -0.27 0.42 -0.20 -0.27 -0.26 -0.32 -0.19 -0.18 -0.21
EPS in Rs -1.95 -0.08 -0.15 -0.01 -0.14 0.22 -0.10 -0.14 -0.14 -0.17 -0.10 -0.09 -0.11
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
19.86 33.86 30.27 12.24 1.35 2.84 4.09 0.83 0.00 0.00 0.03 0.00 0.00
18.55 31.14 27.43 11.43 1.84 9.72 4.62 1.56 0.67 4.14 0.71 0.95 0.89
Operating Profit 1.31 2.72 2.84 0.81 -0.49 -6.88 -0.53 -0.73 -0.67 -4.14 -0.68 -0.95 -0.89
OPM % 6.60% 8.03% 9.38% 6.62% -36.30% -242.25% -12.96% -87.95% -2,266.67%
0.18 0.27 0.01 0.00 0.00 0.03 0.06 0.02 0.01 0.20 0.26 0.02 0.11
Interest 0.94 1.40 1.20 1.08 0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.53 0.58 0.68 0.65 0.62 0.59 0.59 0.59 0.57 0.56 0.51 0.15 0.16
Profit before tax 0.02 1.01 0.97 -0.92 -1.19 -7.44 -1.06 -1.30 -1.23 -4.50 -0.93 -1.08 -0.94
Tax % 50.00% 50.50% 50.52% 26.09% 0.84% 0.81% 17.92% 3.85% 5.69% 1.78% 84.95% 1.85%
0.00 0.50 0.46 -0.68 -1.19 -7.39 -0.87 -1.25 -1.17 -4.42 -0.14 -1.05 -0.90
EPS in Rs 0.00 0.53 0.31 -0.45 -0.62 -3.87 -0.46 -0.65 -0.61 -2.31 -0.07 -0.55 -0.47
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -100%
Compounded Profit Growth
10 Years: %
5 Years: -5%
3 Years: 3%
TTM: -190%
Stock Price CAGR
10 Years: -2%
5 Years: 11%
3 Years: 65%
1 Year: 53%
Return on Equity
10 Years: -17%
5 Years: -25%
3 Years: -43%
Last Year: -32%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 9.35 9.35 15.03 15.03 19.11 19.11 19.11 19.11 19.11 19.11 19.11 19.11 19.11
Reserves 1.38 1.88 2.35 1.06 -0.13 -7.50 -8.35 -9.58 -10.75 -15.16 -15.29 -16.32 -16.68
11.45 13.55 8.22 7.78 6.65 2.90 2.90 2.51 2.53 5.68 5.81 6.77 7.05
1.40 4.46 9.22 8.49 2.94 6.41 5.49 5.52 5.52 1.67 0.53 0.63 0.65
Total Liabilities 23.58 29.24 34.82 32.36 28.57 20.92 19.15 17.56 16.41 11.30 10.16 10.19 10.13
9.74 9.47 15.18 8.21 7.64 7.06 6.47 5.88 5.26 4.68 4.17 4.14 4.07
CWIP 0.00 0.00 0.00 6.15 6.15 5.51 5.21 5.43 5.02 3.90 3.42 3.40 3.36
Investments 0.92 0.92 0.92 0.92 0.92 0.92 0.92 0.92 0.92 0.54 0.54 0.54 0.54
12.92 18.85 18.72 17.08 13.86 7.43 6.55 5.33 5.21 2.18 2.03 2.11 2.16
Total Assets 23.58 29.24 34.82 32.36 28.57 20.92 19.15 17.56 16.41 11.30 10.16 10.19 10.13

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-1.61 0.02 4.62 2.16 1.25 0.37 -0.34 0.61 -0.49 -0.93 -4.34 -0.87
-0.39 -0.29 -6.39 -0.44 -0.05 0.63 0.30 -0.22 0.46 1.54 0.46 -0.10
1.80 0.27 1.72 -1.75 -1.19 -0.98 0.00 -0.39 0.03 -0.61 3.88 0.96
Net Cash Flow -0.20 0.00 -0.05 -0.03 0.01 0.02 -0.04 0.00 0.00 0.00 0.00 -0.01

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 53.11 65.43 104.30 229.02 1,154.48 532.08 344.47 1,147.77 365.00
Inventory Days 155.28 115.62 94.81 274.40 6,543.93 50.05 58.94 253.72 4,015.00 4,562.50
Days Payable 5.77 34.54 62.46 123.03 556.19 15.95 14.48 71.22 876.00 1,825.00
Cash Conversion Cycle 202.62 146.52 136.65 380.39 7,142.22 566.19 388.94 1,330.27 3,504.00
Working Capital Days 213.74 154.15 148.56 327.72 2,509.04 257.04 171.34 255.06 21,291.67
ROCE % 4.60% 10.26% 8.61% 0.65% -4.48% -37.07% -7.53% -10.12% -10.73% -45.61% -9.66% -11.26%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
35.89% 35.89% 35.89% 35.89% 35.89% 35.89% 35.89% 35.89% 35.89% 35.89% 35.89% 35.89%
64.11% 64.11% 64.11% 64.11% 64.11% 64.11% 64.11% 64.11% 64.11% 64.11% 64.11% 64.11%
No. of Shareholders 4,6004,5804,5644,5484,5384,5284,5294,5124,4944,4754,4544,435

Documents